Tyra Biosciences, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 21 →InsidersNo open-market buys. 3 insiders sold $10.6M, 13 of 14 sales on a 10b5-1 plan.→HoldersRa 20.4%FMR 15.0%Jupiter Topco 7.3%→Financing →PeersClosest companies: PMVP, BDTX, RLAY→
From the filings
Figures
- Net income
- −$148.6Mlast 12 months
- Operating cash flow
- −$102.3Mlast 12 months
- Cash and equivalents
- $73.8Mat the last balance sheet
- Shares outstanding
- 59.7M shareson issue